<html><head><title>Diagnostic Testing</title></head><body>
<h2>Papers tagged with: Diagnostic Testing</h2>
<ul>
<li>Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing</li>
<li>The reliability of the ankle brachial index: A systematic review</li>
<li>Estimating the diagnostic accuracy of the ankle?brachial pressure index for detecting peripheral arterial disease in people with diabetes: A systematic review and meta-analysis</li>
<li>Convergent and criterion validity of PROMIS anxiety measures relative to six legacy measures and a structured diagnostic interview for anxiety in cancer patients</li>
<li>Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial</li>
<li>Cardiac Calcium Release Channel (Ryanodine Receptor 2) Regulation by Halogenated Anesthetics</li>
<li>Safety and care of no fasting prior to catheterization laboratory procedures: a non-inferiority randomized control trial protocol (SCOFF trial)</li>
<li>Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial</li>
<li>The receptor tyrosine kinase trka is increased and targetable in HER2-positive breast cancer</li>
<li>CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR Trial</li>
<li>TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol</li>
<li>Serum L-arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A~nested case-control study</li>
<li>Lack of consensus in atypical congenital obstructive urethral lesions in children: Snapshot of the web-based ObsCUre (obstruction to the child urethra) study</li>
<li>Assessing the impact of magnetic resonance treatment simulation (MRSIM) on target volume delineation and dose to organs at risk for oropharyngeal radiotherapy</li>
<li>Bladder carcinomain situ({CIS}) in Australia: a rising incidence for an under-reported malignancy</li>
</ul>
</body></html>
